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Sequential similarities between the tryptophan peptide of myelin basic protein (residues ill-121), 
luteinizing hormone releasing hormone, melanotropin, adrenocorticotropin (residues l-13), human 
leukocyte interferon (residues 28-40), and various egments of human and bovine serum albumin and hen 
ovalbumin are presented. It is suggested that these structural similarities may explain observations 
concerning common functional characteristics such as serotonin modulation, immunological activity with 
the adjuvant muramyl dipeptide, immunological cross-reactivity, and the possible MSH-ACTH-like 
activity of a pepsin-derived peptide of interferon. 
MSH ACTH LHRH Myelin basic protein Interferon Albumin 
1. INTRODUCTION 
Authors in [l-3] have reported that anti-sera to 
cy-melanotropic hormone (MSH) (which also cor- 
responds to a-adrenocorticotropic hormone, 
residues 1-13 [ACTH (l-13)]) cross-reacts with 
human leukocyte interferon (cuIFN). “Conversely, 
anti-sera to human leukocyte interferon neutral- 
ized ACTH activity,” They further claim that an 
unidentified pepsin-derived peptide from aIFN 
possessed ACTH-like activity. Anti-sera to MSH- 
ACTH (1-13) did not cross-react with fibroblast 
interferon (,&IFN). No cross-reactivity was ob- 
served between ant&era to luteinizing hormone 
(LH) or follicle-stimulating hormone (FSH) and 
human leukocyte interferon. Assuming a correla- 
tion between immunological cross-reactivity and 
structural similarity [4], these observations uggest 
that MSH-ACTH (l- 13) and some portion of 
cvIFN are structurally similar [5]. Authors in [5] 
and in [6] have both reported that no significant 
degree of homology exists between ACTH and 
cuIFN, and the latter authors [6] have not been able 
to replicate the results of those in [l-3]. However, 
they did not use the same system as that in [l-3] 
for testing the reported results, nor did they test 
for ACTH-like activity of a peptide fragment of 
&FN. Thus, while there is some question as to the 
validity of the results in [l-3], it was deemed of 
sufficient interest to take another look at the 
possibility of a structural similarity between MSH- 
ACTH (1-13) and aIFN. A sequential similarity 
was, in fact, found, and, in the process, similarities 
between ACTH and aIFN were found with a 
number of other peptides and protein secjuences. 
2. METHODS 
The method used for locating the sequential 
similarity is based upon theoretical and experimen- 
tal considerations of the active sites of peptide hor- 
mones. Authors in [7] have suggested that active 
sites of peptide hormones usually, if not always, 
contain one or more aromatic residues. The author 
in [S] has suggested further that pairs of aromatic 
residues at active sites form ‘molecular sand- 
wiches’ comprised of two aromatic residues 
separated by a hydrophilic one that can intercalate 
Published by Elsevier Science Publishers B. V. 
00145793/84/$3.00  1984 Federation of European Biochemical Societies 208 
Volume 168, number 2 FEBS LETTERS March 1984 
aromatic amines such serotonin 
(Shydroxytryptamine [5HT]), i:pamine, and 
histamine. Authors in [9,10] located one such 
SHT-binding site on the tryptophan peptide of 
myelin basic protein (residues 111-121) (table 1) 
that contains a molecular sandwich [8]. It was then 
demonstrated by means of NMR spectroscopy that 
the molecular sandwich model of 5HT binding to 
tryptophan peptide agrees with observed modes of 
interaction and that similar mo!ecular sandwiches 
exist on MSH, ACTH, and luteinizing hormone- 
releasing hormone (LHRH) (table 1) [l 11. It has 
been shown further that the proposed molecular 
sandwiches correspond to the known active sites of 
MSH, ACTH, and LHRH [12-161. The report in 
[l-3] of cross-reactivity between MSH-ACTH 
( I- 13) and human leukocyte interferon correlated 
with the ACTH-like activity of a human leukocyte 
Table 1 
Search for sequence homology to the molecular sandwiches of MSH, ACTH, LHRH, and tryptophan peptide 
Myelin basic protein (111-121) 
LHRH 
Ser -Arg-Phe- Ser -Trp-Gly-Ala-Glu-Gly-Gln-Arg 
<Glu-His-Trp-Ser-Tyr-Gly-Glu-Arg-Pro-NH2 = 
ACTH-MSH (1-13) 
(Phe substitution active) 
Human leukocyte interferon 
(cu) (28-40) 
Human fibroblast interferon 
W) (28-40) 
Human serum albumin (S-15) 
(bovine identical) 
Human serum albumin (330-337) 
(bovine in parentheses) 
Human serum albumin (503-5 12) 
(bovine in parentheses) 
Chicken ovalbumin (94-104) 
(Phe) 
Ser-Tyr- Ser -Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val - --- - 
Ser-Cys-Leu-Met-Asp-Arg-His-Asp-Phe-Gly-Phe-Pro-Gln - -- - - 
Ser-Cys-Leu-Lys-Asp-Arg-Met-Asn-Phe-Asp- Ile - Pro-Glu - - - 
Ser-Glu-Val-Ala-His-Arg-Phe-Lys-Asp-Leu-Gly 
(Ser) (Ser) 
Met-Phe-Leu-.Tyr-Glu-Tyr-Ala-Arg-Q 
(Asp-Glu-Lys-Leu) 
Asn-Ala-Glu-Thr-Phe-Thr-Phe-His-Ala-Asp 
Asn-Asp-Val-Tyr- Ser -Phe- Ser -Leu-Ala- Ser -Arg 
The sequences (top to bottom) of the tryptophan peptide of myelin basic protein [36]; luteinizing hormone-releasing 
hormone [13]; melanotropic hormone (MSH) (which corresponds to adrenocorticotropic hormone, residues 1-13 
[ACTH (l-13)]) [ 121; human leukocyte interferon IFN-(rl, residues 28-40 [17]; human fibroblast interferon BIFN [ 171; 
human and bovine serum albumin [21,22]; and hen ovalbumin [23]. The active sites (molecular sandwiches [8]) of 
tryptophan peptide, LHRH and MSH-ACTH (1-13) [ll-161 are double underlined. Note that Phe but not Ile may 
replace Trp without loss of activity in MSH-ACTH (1-13) [12]. These sequences are known to bind serotonin, and in 
the case of MSH-ACTH (l-13), histamine as well Ill]. The molecular sandwich of human leukocyte interferon is also 
double underlined. Note that it retains the same components and structure of the other molecular sandwiches although 
differing in absolute sequence. Other homologies between MSH-ACTH (l-13) and tryptophan peptide, LHRH, human 
leukocyte interferon (28-40), and human fibroblast interferon (28-40) are indicated by single underlines. Note that 
while human fibroblast interferon (28-40) has many shared residues with human leukocyte interferon (28-40), it lacks 
a molecular sandwich and has a few other similarities to MSH-ACTH (1-13). The albumins also contain molecular 
sandwiches imilar to the SHT-binding sites of tryptophan peptide, LHRH, and MSH-ACTH. As noted in the text, 
no molecular sandwiches were found on follicle-stimulating hormone or luteinizing hormone [19], nor were 5HT- 
binding sites found on delta sleep inducing peptide, gastrin, somatostatin, enkephalin, or proctolin [l I] 
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interferon peptide then suggested that interferon 
might also possess an active site composed of a 
molecular sandwich similar to the SHT-binding 
sites already elucidated. A search of the interferon 
sequence [17,18] was therefore made for a se- 
quence homologous to the molecular sandwiches 
of MSH, ACTH, LHRH, and tryptophan peptide. 
3. RESULTS 
The results of the search are shown in table 1. 
Only one molecular sandwich bearing any struc- 
tural similarity to the SHT-binding site of MSH- 
ACTH (1-13) was found on human leukocyte in- 
terferon: residues 33-36. Like previous molecular 
sandwiches, it consists of two aromatic residues 
separated by a hydrophilic residue. The human 
leukocyte interferon ‘sandwich’ sequence, while 
not identical to the ACTH sequence, is composed 
of functionally similar residues. The amino acid 
composition of the sandwich is, in addition, very 
similar to that of ACTH, and the sandwich is 
flanked by 5 further residues within the sequence 
28-40 that are identical to those in similar posi- 
tions flanking the ACTH sandwich. In all, 8 of the 
13 residues (28-40) in human leukocyte interferon 
are functionally analogous or identical to residues 
appearing in the same positions in MSH-ACTH 
(l- 13). Because some of the residues are only 
functionally analogous and not identical, the 
similarities in sequence that I have proposed could 
not have been found by authors in [5] or [6] who 
looked for identities. 
Human fibroblast interferon (& type) differs 
significantly from human leukocyte interferon [ 171 
in ‘the region of suggested homology to MSH- 
ACTH (1-13). In the first place, the molecular 
sandwich is absent: the His at position 34 is re- 
placed with Met. Four other residues are sub- 
stituted with functionally different amino acids, 
and one other (Gln for Glu at position 40) residue 
is also altered. This leaves only 3 of the residues 
held in common between human leukocyte inter- 
feron and MSH-ACTH (l- 13) unaltered. No other 
ACTH-like homologies were found. 
Only one possible molecular sandwich was 
found on aFSH (residues 84-92) and czLH 
(residues 82-90), and it is a sequence common to 
both: Cys-Ser-Thr-Cys-Tyr-Tyr-His-Lys-Ser [ 191. 
Except for the existence of a pair of aromatic 
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residues separated by a hydrophilic one (Tyr-Tyr- 
His), this sequence bears no similarities whatever 
to MSH-ACTH (1-13) or to human leukocyte in- 
terferon (28-40). The only possible molecular 
sandwich found on PFSH was a sequence in which 
a Cys separated two Tyr [ 181. This Cys is involved 
in forming a disulfide bridge in the natural confor- 
mation and so is unavailable to participate as part 
of an active site [20]. In any case the sequence of 
which these residues are a part (28-36) is not 
homologous to MSH-ACTH (1-13) or human 
leukocyte interferon (28-40). No molecular sand- 
wiches were found on PLH [ 191. Experiments have 
demonstrated that no SHT-binding sites exist on 
delta sleep-inducing peptide, gastrin, somato- 
statin, enkephalin, or proctolin [ 111. Several mole- 
cular sandwiches similar to those of ACTH, 
LHRH, etc., were found, however, on human 
serum albumin [21], bovine serum albumin [22] 
and chicken ovalbumin [23] (table 1). 
4. DISCUSSION 
The proposed homology between MSH-ACTH 
(1-13) and human leukocyte interferon (28-40) is 
consistent with a large number of observations. It 
explains the observed cross-reactivity between 
MSH-ACTH (1-13) anti-sera and human 
leukocyte interferon and vice versa; the lack of 
cross-reactivity between MSH-ACTH (l-13) anti- 
sera and human fibroblast interferon; and the lack 
of cross-reactivity between anti-sera to LH and 
FSH with human leukocyte interferon [I]. It also 
accounts for the MSH-ACTH-like activity of a 
pepsin-derived peptide of human leukocyte in- 
terferon [l], since the proposed sequence contains 
an active site (molecular sandwich) similar to that 
previously identified on MSH-ACTH [ 12- 161. In- 
deed, it is known that a tryptic digest of leukocyte 
interferon yields a peptide composed of residues 
32-45 [24]. Since this peptide contains most of the 
homologous region including the active site, it may 
have MSH-ACTH-like activity. 
The proposed homology leads to several other 
testable predictions. MSH, ACTH, and LHRH ac- 
tivities are modulated by 5HT [25-281, and the 
molecular sandwiches on these hormones and tryp- 
tophan peptide act as SHT-binding sites [lO,ll]. 
The albumins are also known to bind 5HT 
[29-331. It follows that the molecular sandwich on 
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human leukocyte interferon may also act as a 5HT- 
binding site, and thus that 5HT may also modulate 
interferon activity. Model building with CPK 
models suggests the further possibility that, like 
MSH and ACTH [ 1 l], the molecular sandwich on 
human leukocyte interferon may bind histamine. 
Since SHT and histamine are integrally involved in 
immunological reactions of many kinds [34,35], 
their modulation of interferon activity would not 
be unlikely. It is also noteworthy that the tryp- 
tophan peptide of myelin basic protein and LHRH 
are known to cause experimental autoimmune 
diseases in the presence of mummy1 dipeptide 
[36-391, which has been shown to be a SHT-like 
substance [40,41]. Muramyl dipeptide is also func- 
tional as an adjuvant for bovine serum albumin 
and hen ovalbumin [42,43]. These observations 
suggest a correlation between SHT-binding sites 
and muramyl .dipeptide activity [44] that may be 
extended to include MSH, ACTH, and uIFN. 
These predictions may be tested without great dif- 
ficulty by Merrifield solid-phase synthesis of the 
relevant peptide sequences (table 1). 
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